Posted Apr. 26, 2013 at 5:36 a.m.

Premium Lock GSK drug partner Theravance to split into two ventures

Published: 2013-04-26 05:36:18
Updated: 2013-04-26 05:36:18

GSK  GSK

Theravance formed a partnership with Glaxo a decade ago to develop respiratory treatments. Glaxo is the largest Theravance stakeholder with 27 percent of the company's shares....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll